These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39075633)

  • 21. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
    J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
    Fung CSC; Wan EYF; Chan AKC; Lam CLK
    BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of Non-High-Density Lipoprotein Cholesterol as a Predictor of Cardiovascular Disease Mortality in Men in 22-Year Follow-Up.
    Harari G; Green MS; Magid A; Zelber-Sagi S
    Am J Cardiol; 2017 Apr; 119(8):1193-1198. PubMed ID: 28267961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
    Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
    Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study.
    Hirata A; Sugiyama D; Watanabe M; Tamakoshi A; Iso H; Kotani K; Kiyama M; Yamada M; Ishikawa S; Murakami Y; Miura K; Ueshima H; Okamura T;
    J Clin Lipidol; 2018; 12(3):674-684.e5. PubMed ID: 29506864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dutch Lipid Clinic Network low-density lipoprotein cholesterol criteria are associated with long-term mortality in the general population.
    Séguro F; Bongard V; Bérard E; Taraszkiewicz D; Ruidavets JB; Ferrières J
    Arch Cardiovasc Dis; 2015 Oct; 108(10):511-8. PubMed ID: 26073227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol.
    Tsujimoto T; Kajio H; Sugiyama T
    Am J Cardiol; 2017 Dec; 120(11):1947-1954. PubMed ID: 28951019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Low-Density Lipoprotein Cholesterol with Risk of Coronary Heart Disease and Stroke among Middle-Aged Japanese Workers: An Analysis using Inverse Probability Weighting.
    Al-Shoaibi AAA; Li Y; Song Z; Chiang C; Hirakawa Y; Saif-Ur-Rahman KM; Shimoda M; Nakano Y; Matsunaga M; Aoyama A; Tamakoshi K; Ota A; Yatsuya H
    J Atheroscler Thromb; 2023 May; 30(5):455-466. PubMed ID: 35831131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
    Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
    Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
    Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between lipoprotein cholesterol and future cardiovascular disease and mortality in older adults: a Korean nationwide longitudinal study.
    Kim SH; Son KY
    Lipids Health Dis; 2021 Jan; 20(1):3. PubMed ID: 33407561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
    Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
    Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial.
    Zhou Z; Tonkin AM; Curtis AJ; Murray A; Zhu C; Reid CM; Williamson JD; Ryan J; McNeil JJ; Beilin LJ; Ernst ME; Stocks N; Lacaze P; Shah RC; Woods RL; Wolfe R; Gall S; Zoungas S; Orchard SG; Nelson MR
    J Gerontol A Biol Sci Med Sci; 2024 Apr; 79(4):. PubMed ID: 38038339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular disease.
    Yang L; Yue Q; Fang F; Zhang Y; Liu P; Zhang Z; Wang G; Chen S; Wu S; Yang X
    Cardiovasc Diabetol; 2023 Apr; 22(1):96. PubMed ID: 37095492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study.
    Yoo TK; Han KD; Rhee EJ; Lee WY
    Diabetes Metab J; 2024 Mar; 48(2):265-278. PubMed ID: 38403889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.